Last reviewed: June 29, 2026

Last updated: June 29, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide has transformed weight loss treatment by activating glucagon-like peptide-1 (GLP-1) receptors in the brain and pancreas, reducing hunger signals and improving blood sugar control. Clinical evidence demonstrates that patients using this medication lose significantly more weight than those on diet and exercise alone. PlexusDx delivers compounded semaglutide injections through licensed 503A pharmacies, making this proven therapy accessible across all 50 states without insurance requirements.

How Semaglutide Works for Weight Loss

Semaglutide functions as a GLP-1 receptor agonist, mimicking a natural hormone your body produces after eating. When activated, GLP-1 receptors send satiety signals to your brain, causing you to feel fuller on smaller portions and reducing overall calorie intake. The medication also slows gastric emptying—the rate at which food leaves your stomach—which extends the feeling of fullness between meals. Additionally, semaglutide improves insulin secretion and sensitivity, helping regulate blood sugar levels independently of weight loss.

The GLP-1 pathway involves more than appetite suppression; it influences metabolic rate and fat storage patterns. Research shows that patients maintain weight loss even after reaching their target, suggesting the medication creates lasting behavioral and metabolic adaptations. Individual genetic variations in the GLP1R gene (particularly rs6923761) influence how effectively your body responds to semaglutide therapy, which is why personalized dosing and monitoring yield better outcomes.

Clinical Evidence: Real Weight Loss Results

The STEP clinical trials, conducted over 68 weeks with over 4,500 participants, demonstrated that semaglutide produces average weight loss of 15-22% of baseline body weight when combined with lifestyle modification. In comparison, patients receiving placebo lost approximately 2-3% of body weight. The STEP 1 trial showed that 86% of semaglutide users achieved at least 5% weight loss, while 69% achieved 15% or greater weight loss. These results represent some of the most significant weight loss outcomes ever documented in obesity research.

Long-term follow-up studies extending to 2 years show sustained weight loss maintenance, with most patients preserving 80% or more of the weight they initially lost. Importantly, weight loss was accompanied by improvements in cardiovascular risk factors, including reductions in blood pressure and waist circumference. Patients also reported meaningful improvements in quality of life, mobility, and reduction in obesity-related health complications during these extended observation periods.

Semaglutide Dosing and Your Price Stays Fixed

Semaglutide treatment begins with a low dose and gradually increases over 4-16 weeks to minimize side effects and allow your body to adapt. Most patients reach maintenance doses between 0.5 mg and 2.4 mg weekly, delivered by subcutaneous injection. The dosing schedule is individualized based on tolerability, metabolic response, and clinical goals—your dose may need to increase, but your price at PlexusDx will not. Compounded semaglutide injections start at just $149 per month, flat rate across commitment tiers.

PlexusDx offers three subscription tiers providing flexibility for different patient needs, all with the same transparent per-month cost. No insurance is required, and your medication ships directly to your home from licensed 503A compounding pharmacies. HSA and FSA accounts are eligible, making treatment even more affordable. Your healthcare provider determines the appropriate dose progression, and PlexusDx delivers consistent, high-quality compounded medication at every step.

Genetic Testing for Personalized Semaglutide Response

PlexusDx offers the Precision Peptide Genetic Test ($99 add-on after first month), which analyzes 150+ genetic insights across 14 metabolic pathways and 49 peptides. This test identifies your unique genetic predispositions in key weight regulation genes, including GLP1R (rs6923761), GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313). Understanding your genetic profile helps predict your semaglutide response trajectory and informs personalized dosing strategies that optimize both efficacy and tolerability.

Patients with certain genetic variants in the GLP1R pathway may experience enhanced appetite suppression at lower doses, while others benefit from gradual dose escalation to maximum therapeutic levels. The Precision Peptide test guides your clinician in tailoring your treatment protocol, reducing trial-and-error adjustments and accelerating your path to optimal weight loss. This precision medicine approach represents the intersection of advanced genetics, clinical pharmacology, and personalized care—moving beyond one-size-fits-all weight loss treatment.

Side Effects and Tolerability of Semaglutide

Most common side effects include nausea, vomiting, diarrhea, and constipation, occurring in 25-50% of users during dose escalation phases. These gastrointestinal effects are typically mild to moderate, temporary, and resolve as your body adjusts to the medication. Gradual dose increases reduce the severity of side effects, and many patients experience complete symptom resolution within 1-2 weeks of reaching a stable dose. Taking medication with food, staying hydrated, and adjusting dietary fiber intake can further minimize gastrointestinal symptoms.

Serious side effects are rare but include reports of pancreatitis, gallbladder disease, and thyroid concerns in animal studies—though human clinical trials have not confirmed increased thyroid cancer risk. Semaglutide is contraindicated in patients with personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2. Your PlexusDx provider reviews your complete medical history before prescribing, ensuring safe and appropriate use tailored to your individual health profile.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What percentage of body weight will I lose on semaglutide?

Clinical trials show average weight loss of 15-22% of baseline body weight over 68 weeks when combined with lifestyle changes. Individual results vary based on starting weight, genetics, adherence, and diet quality. PlexusDx patients with genetic predispositions favoring GLP-1 sensitivity may achieve results at the higher end of this range.

How long does it take to see weight loss results from semaglutide?

Most patients notice appetite reduction within the first 1-2 weeks of treatment. Measurable weight loss typically becomes apparent after 4-8 weeks, with progressive results continuing over the 68-week trial period and beyond. Genetic factors, including FTO and MC4R variants, influence the speed of initial weight loss.

What is the cost of semaglutide at PlexusDx?

PlexusDx compounded semaglutide injections start at $149 per month, with pricing remaining flat regardless of dose level across three subscription tiers. No insurance is required, and HSA/FSA accounts are eligible. The Precision Peptide Genetic Test is available for $99 as an add-on after your first month of treatment.

Can I stop semaglutide once I reach my goal weight?

Most weight loss is maintained for 1-2 years after stopping semaglutide, though some weight regain may occur. Long-term therapy is often recommended to sustain results and prevent metabolic rebound. Your PlexusDx provider helps determine the optimal treatment duration based on your goals and response.

Does the Precision Peptide Genetic Test predict my semaglutide effectiveness?

Yes, the Precision Peptide Genetic Test analyzes your GLP1R, GIPR, FTO, and MC4R variants across 14 metabolic pathways. These insights help predict your individual response to semaglutide, guide dose progression, and optimize your personalized treatment protocol for faster, more effective weight loss outcomes.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves